IN8bio, Inc. (INAB) Tops Q3 EPS by 2c

IN8bio, Inc. (NASDAQ: INAB) reported Q3 EPS of ($0.23), $0.02 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on IN8bio, Inc. (INAB) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• Samsung Electronics Co Ltd. (005930:KS) (SSNLF) PT Raised to KRW550,000 at BofA Securities
• Freedom Broker Starts Holley (HLLY) at Buy